| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiotensin 1–7 and risk for breast cancer recurrence
|
Altundag, Kadri
|
|
2005
|
58 |
2 |
p. 283
|
artikel
|
| 2 |
Antiproliferative and Antiproteolytic activity of Pentoxifylline in cultures of B16F10 Melanoma cells
|
Dua, Pooja
|
|
2005
|
58 |
2 |
p. 195-202
|
artikel
|
| 3 |
A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors
|
Gan, Hui K.
|
|
2005
|
58 |
2 |
p. 157-164
|
artikel
|
| 4 |
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors
|
Pitot, Henry C.
|
|
2005
|
58 |
2 |
p. 165-172
|
artikel
|
| 5 |
Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
|
Carpeño, Javier Castro de
|
|
2005
|
58 |
2 |
p. 266-271
|
artikel
|
| 6 |
Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro
|
Simoens, Cindy
|
|
2005
|
58 |
2 |
p. 210-218
|
artikel
|
| 7 |
5-Fluorouracil can cross brain–blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma
|
Formica, V.
|
|
2005
|
58 |
2 |
p. 276-278
|
artikel
|
| 8 |
Folate receptor specific anti-tumor activity of folate–mitomycin conjugates
|
Reddy, Joseph A.
|
|
2005
|
58 |
2 |
p. 229-236
|
artikel
|
| 9 |
Gemcitabine aerosol: in vitro antitumor activity and deposition imaging for preclinical safety assessment in baboons
|
Gagnadoux, Frédéric
|
|
2005
|
58 |
2 |
p. 237-244
|
artikel
|
| 10 |
Molecular targets of cancer chemotherapy
|
Zaenker, K. S.
|
|
2005
|
58 |
2 |
p. 279-282
|
artikel
|
| 11 |
Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells
|
Stordal, Britta K.
|
|
2005
|
58 |
2 |
p. 256-265
|
artikel
|
| 12 |
Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors
|
Yamada, Yasuhide
|
|
2005
|
58 |
2 |
p. 173-182
|
artikel
|
| 13 |
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisation
|
Delord, Jean-Pierre
|
|
2005
|
58 |
2 |
p. 189-194
|
artikel
|
| 14 |
Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients
|
Sandström, M.
|
|
2006
|
58 |
2 |
p. 143-156
|
artikel
|
| 15 |
Potassium oxonate, an enzyme inhibitor compounded in S-1, reduces the suppression of antitumor immunity induced by 5-fluorouracil
|
Yamashita, Tetsuro
|
|
2005
|
58 |
2 |
p. 183-188
|
artikel
|
| 16 |
Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity
|
Shan, Siqing
|
|
2005
|
58 |
2 |
p. 245-255
|
artikel
|
| 17 |
Reply to letter to the editors (K Altundag et al.)
|
diZerega, Gere S.
|
|
2005
|
58 |
2 |
p. 284
|
artikel
|
| 18 |
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial
|
Dongiovanni, Vincenzo
|
|
2005
|
58 |
2 |
p. 203-209
|
artikel
|
| 19 |
The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro
|
Pauwels, Bea
|
|
2005
|
58 |
2 |
p. 219-228
|
artikel
|
| 20 |
Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency
|
Ciccolini, Joseph
|
|
2005
|
58 |
2 |
p. 272-275
|
artikel
|
Tijdschrift beschrijving